Now Is The Time For Independent Industry Self-Regulation

By Eric Reicin (April 13, 2023, 6:27 PM EDT) -- When French drugmaker Sanofi SA and Danish pharmaceutical giant Novo Nordisk both announced last month that they will lower prices of their insulin products in the United States, close on the heels of a similar announcement by Eli Lilly & Co., the moves were hailed by many in Washington as a long overdue step in lowering Americans' medical bills....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!